| __timestamp | ACADIA Pharmaceuticals Inc. | Alkermes plc |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 199905000 |
| Thursday, January 1, 2015 | 90804000 | 311558000 |
| Friday, January 1, 2016 | 186456000 | 374130000 |
| Sunday, January 1, 2017 | 255062000 | 421578000 |
| Monday, January 1, 2018 | 265758000 | 526408000 |
| Tuesday, January 1, 2019 | 325638000 | 599449000 |
| Wednesday, January 1, 2020 | 388661000 | 538827000 |
| Friday, January 1, 2021 | 396028000 | 560977000 |
| Saturday, January 1, 2022 | 369090000 | 605747000 |
| Sunday, January 1, 2023 | 402466000 | 689751000 |
| Monday, January 1, 2024 | 645238000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Over the past decade, Alkermes plc and ACADIA Pharmaceuticals Inc. have demonstrated distinct strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Alkermes consistently outpaced ACADIA, with SG&A expenses peaking at approximately 690 million in 2023, a 245% increase from 2014. In contrast, ACADIA's expenses grew by over 1,100% during the same period, reaching around 402 million in 2023. This divergence highlights Alkermes' steady growth and ACADIA's rapid expansion. Such insights are invaluable for investors and stakeholders aiming to understand the financial health and strategic priorities of these companies. As the biopharma sector evolves, monitoring these trends will be key to predicting future market dynamics.
Selling, General, and Administrative Costs: Pfizer Inc. vs Alkermes plc
Amgen Inc. or Alkermes plc: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Alkermes plc
Summit Therapeutics Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Insmed Incorporated or Alkermes plc
BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Alkermes plc vs Opthea Limited
Analyzing R&D Budgets: Alkermes plc vs ACADIA Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Alkermes plc vs Merus N.V.
Rhythm Pharmaceuticals, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Protagonist Therapeutics, Inc.